SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : A US National Health Care System?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter Dierks who wrote (4410)2/11/2008 9:59:59 PM
From: J_F_Shepard  Read Replies (2) of 42652
 
EU companies typically spend about 20% of revenues on R&D.
In 2003 there were almost 7,000 drugs in active R&D in the EU.
As a percentage of GDP, we are by no means the biggest R&D spenders in the world.....Japan, Finland, Sweden spend more. We are 4th followed closely by Germany and Switzerland.

" If the US is the most profitable market then essentially American consumers are funding the research for the whole world. Every consumer outside of the US that benefits from new drugs is essentially a free rider on American consumer purchases."

In 2003 R&D, North America (US and Canada) spent about 29B Euro's (50%) , the EU spent 21B Euro's(33%), Japan spent about 10B Euro's.(11%) So we are hardly funding the R&D for the whole world.
2003 sales are almost exactly the same proportion, ie US 49%, EU 33%, and JP 10%. So this doesn't support your argument.

I can't comment on whether your impression is fair because it isn't true.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News